Home • Industry Projects • Dendreon Biopharmaceutical Manufacturing Plant, Seattle • Image 5

Provenge is expected to be approved by the FDA soon, as additional evidence from clinical trials has been produced.

«Back

---

Home | New On This Site | Products & Services | Company A-Z | Industry Projects | Features | White Papers | Jobs & Careers | Industry News | Events & Exhibitions | Newsletter Sign-Up | Organisations | About Us | Contact Us | Advertise With Us |